Suzano (SUZB3) Investor Day 2025 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2025 summary
12 Dec, 2025Strategic Priorities and Business Focus
Shifting from five to two main strategic drivers: competitiveness and extracting value from recent investments, with growth to come from operational improvements rather than new projects or M&A in the next 2-3 years.
Emphasis on reducing operational disbursements and achieving a net debt/EBITDA target below 2.5x, with a new net debt target of $11 billion across the cycle.
Value extraction from previous capital allocation and acceleration of the fiber-to-fiber strategy are key levers.
No major divestments planned, but selective asset sales and infrastructure monetization are under consideration.
CapEx guidance revised downward, with further compression expected as major projects conclude and forestry productivity rises.
Market Outlook and Competitive Landscape
Pulp capacity expansions in Latin America and Asia, with accelerated integrated capacity in China, are reshaping the competitive landscape and increasing pressure on non-integrated players.
Market BHKP demand is projected to grow at a 2.1% CAGR from 2024 to 2029, mainly driven by emerging markets, especially China.
Forecasting 3.1 million tons of hardwood pulp demand growth and 4 million tons of new capacity by 2029, resulting in a suboptimal demand/capacity ratio and unsustainable industry margins.
Vertical integration in Asia is expected to grow, challenging competitiveness in Western markets and putting pressure on cash costs.
Industry expects closures of high-cost, non-competitive mills, especially in Europe and North America, and potential de-verticalization to create new market opportunities.
Operational and Financial Performance
Major operational turnaround at Pine Bluff and above-plan performance at the Cerrado Project, with Ribas do Rio Pardo exceeding design capacity in its first year, producing 2.3 MT, 16% above target, with no additional capex required.
Over 70 cost and efficiency initiatives identified, targeting a total operational disbursement of BRL 1,983/ton by 2027, maintaining last year’s forecast despite inflation.
Competitiveness acceleration program includes 77 initiatives across genetics, logistics, industry, and supply management, with significant cost reduction targets.
Strong liquidity position, with $4 billion in new debt issued at competitive rates, and all 2025 debt issuances below the company’s bond curve, achieving the lowest G-Spread ever on the 2036 bond.
Consistent hedging policy protects cash flow against FX risk, and average cost of debt continues to decline despite a volatile environment.
Latest events from Suzano
- Record sales, cost discipline, and strong liquidity support a positive outlook.SUZB3
Q4 202511 Feb 2026 - EBITDA up 60% year-over-year, but net loss of R$3.77B on FX and derivative impacts.SUZB3
Q2 20241 Feb 2026 - EBITDA and sales volumes surged, with Ribas ramp-up and acquisitions boosting performance.SUZB3
Q3 202418 Jan 2026 - Cost leadership, operational excellence, and disciplined capital allocation drive growth.SUZB3
Investor Day 202411 Jan 2026 - Record sales and EBITDA driven by Ribas ramp-up, but FX losses led to a net loss.SUZB3
Q4 20248 Jan 2026 - Strong sales growth, robust cash flow, and major strategic moves marked the quarter.SUZB3
Q2 202523 Nov 2025 - Net income rose to R$6.3B in 1Q25, with stable leverage and strong free cash flow.SUZB3
Q1 202518 Nov 2025 - JV creates a global tissue leader with $3.3bn revenue, $175M synergies, and strong diversification.SUZB3
Investor Update12 Nov 2025 - Cash cost below BRL 800/ton, EBITDA down 20%, leverage up, 2025 capex guidance reaffirmed.SUZB3
Q3 20257 Nov 2025